A Single Dose Study to Assess the Regional Absorption and Bioavailability of 100mg GSK2190915A

NCT01318980 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: GSK2190915 100mg milled tablet
DRUG: [14C] radiolabelled GSK2190915 solution
DRUG: GSK2190915 100mg milled tablet administered to the proximal small bowel.
DRUG: GSK2190915 100mg milled tablet administered to the distal small bowel.
DRUG: GSK2190915 100mg enteric-coated tablet.

Sponsor

GlaxoSmithKline